智通财经APP讯，金威医疗(08143)发布公告，公司建议按于记录日期每持有1股现有股份获发1股供股股份的基准，以认购价每股供股股份0.05港元(i)发行最多5.64亿股供股股份而筹集最多约2820万港元(假设供股获全数认购及于记录日期或之前已发行现有股份数目并无变动);或(ii)发行最多5.83亿股供股股份而筹集最多约2920万港元(假设供股获全数认购及于记录日期或之前全数转换可换股优先股后配发及发行新股份)的所得款项总额。
经扣除所有相关开支后，供股最高所得款项净额估计(i)约为2670万港元(假设于记录日期或之前供股获全数认购及已发行现有股份数目并无变动);或(ii)约为2770万港元(假设供股获全数认购及于记录日期或之前全数转换可换股优先股后配发及发行新股份)。经扣除供股相关开支后，每股供股股份净价将约为0.047港元(假设供股获全数认购及现有股份数目并无变动)或约0.047港元(假设供股获全数认购及于记录日期或之前全数转换可换股优先股后配发及发行新股份)。
假设供股获全数认购及于记录日期或之前已发行现有股份数目并无变动，公司拟将供股所得款项净额：约39.7%用于偿还股东贷款;约31.1%用于发展集团的综合性医院业务;约29.2%用作集团一般营运资金。
假设供股获全数认购及于全数转换可换股优先股后配发及发行新股份，公司拟将供股所得款项净额：约38.3%用于偿还股东贷款;约30.0%用于发展集团的综合性医院业务;约31.8%用作集团一般营运资金。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.